Chemoinformaics analysis of 2-Acetyl-1-methylpyrrole
| Molecular Weight | 123.155 | nRot | 1 |
| Heavy Atom Molecular Weight | 114.083 | nRig | 6 |
| Exact Molecular Weight | 123.068 | nRing | 1 |
| Solubility: LogS | -1.16 | nHRing | 1 |
| Solubility: LogP | 1.195 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 2 | APOL | 19.5931 |
| nHD | 0 | BPOL | 11.6069 |
| QED | 0.515 |
| Synth | 2.315 |
| Natural Product Likeliness | -1.287 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.014 |
| HIA | 0.008 |
| CACO-2 | -4.522 |
| MDCK | 0.0000351 |
| BBB | 0.963 |
| PPB | 0.204645 |
| VDSS | 1.633 |
| FU | 0.750009 |
| CYP1A2-inh | 0.958 |
| CYP1A2-sub | 0.939 |
| CYP2c19-inh | 0.535 |
| CYP2c19-sub | 0.727 |
| CYP2c9-inh | 0.048 |
| CYP2c9-sub | 0.348 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.55 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.266 |
| CL | 9.17 |
| T12 | 0.773 |
| hERG | 0.012 |
| Ames | 0.079 |
| ROA | 0.708 |
| SkinSen | 0.116 |
| Carcinogencity | 0.673 |
| EI | 0.845 |
| Respiratory | 0.217 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.922172 |